Author:
Haberkorn Uwe,Hoffend Johannes,Schmidt Kerstin,Altmann Annette,Bonaterra Gabriel A.,Dimitrakopoulou-Strauss Antonia,Strauss Ludwig G.,Eisenhut Michael,Kinscherf Ralf
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine
Reference48 articles.
1. Laird AD, Vajkoczy P, Shawver LK, Thurnher A, Liang C, Mohammadi M, et al. SU6668 is a potent antiangiogenic and antitumour agent that induces regression of established tumours. Cancer Res 2000;60:4152–60.
2. Herbst RS, Hess KR, Tran HT, Tseng JE, Mullani NA, Charnsangavej C, et al. Phase I study of recombinant human endostatin in patients with advanced solid tumours. J Clin Oncol 2002;20:3792–803.
3. Kerr C. Bevacizumab and chemotherapy improves survival in NSCLC. Lancet Oncol 2005;6:266.
4. Schmidt K, Hoffend J, Altmann A, Strauss LG, Dimitrakopoulou-Strauss A, Engelhardt B, et al. Transfer of the sFLT-1 gene in Morris hepatoma results in decreased growth and perfusion and induction of genes associated with stress response. Clin Cancer Res 2005;11:2132–40.
5. Schmidt K, Hoffend J, Altmann A, Kiessling F, Strauss LG, Koczan D, et al. Troponin I overexpression inhibits tumour growth, perfusion and vascularization of Morris hepatoma. J Nucl Med 2006;47:1506–14.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献